Dextromethorphan PCD Pharma Franchise Company

Cafoli Lifecare offers a Dextromethorphan range of 14 formulations across syrup, suspension, softgel and tablets, manufactured in WHO-GMP certified facilities. Distributors building a cough-cold and respiratory portfolio can secure district-wise monopoly franchise rights with full promotional support.

What is Dextromethorphan?

Dextromethorphan is a centrally acting cough suppressant (antitussive) that raises the cough threshold in the brain without causing narcotic dependence. It is widely used, often with antihistamines and decongestants, to relieve dry, non-productive cough. Reference: PubChem - Dextromethorphan.

Available Forms

The Cafoli Dextromethorphan portfolio includes cough Syrup and Suspension, Softgel and Tablets, commonly combined with chlorpheniramine, phenylephrine and guaiphenesin. Contact us for current pack presentations and combinations.

Therapeutic Applications

Dextromethorphan is used for the symptomatic relief of dry, irritating, non-productive cough associated with colds and upper-respiratory infection. Prescribers include chest physicians, paediatricians, ENT specialists and general practitioners.

Why Dextromethorphan is a High-Potential Molecule for Distributors

Cough-cold is the highest-frequency reason for OPD visits in India, and antitussive syrups move in very high seasonal volume across every chemist. Dextromethorphan is the standard dry-cough suppressant, so its wide combination range gives distributors dependable, fast-turnover retail sales that anchor a respiratory line.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers monopoly franchise rights, WHO-GMP certified manufacturing, DCGI-approved formulations, a network of 1000+ franchise partners across India, and free promotional inputs.

References

1. PubChem: Dextromethorphan
2. MedlinePlus: Dextromethorphan
3. PubMed: dextromethorphan for cough